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RELATO DE CASO 
HELLP SYNDROME WITH PLACENTAL ABRUPTION AND FETAL 
DEATH: A CASE REPORT 
SÍNDROME HELLP COM DESCOLAMENTO PLACENTÁRIO E ÓBITO 
FETAL: RELATO DE CASO 
Carlos Alberto Rodrigues Junior1, Fellipe Camargo Ferreira Dias1, Flávia da 
Silva Oliveira2, Gustavo Santos Sousa1, Fábio Roberto Ruiz de Moraes3, Ana 
Carolina Batista de Souza Guedes4. 
ABSTRACT 
The HELLP syndrome – defined as haemolysis, elevated liver enzymes and 
thrombocytopenia – consists of an advanced stage of preeclampsia (PE), which 
can affect 0.6% of pregnancies and 4-12% of patients with severe PE. Being 
responsible for elevated maternal and perinatal mortality rates, it can present 
with general malaise, epigastralgia, right hypochondrium pain, nausea and vomits, 
headache, scotomas, associated with hypertension and proteinuria. Woman, 19 
years old, primigest, admitted with 29 weeks of gestational age presenting with 
arterial hypertension (160/120 mmHg), headache, scotomas, nausea and vomits. 
She showed regular health status, pallid, closed, anterior and soft cervix, with no 
fluid losses, and inaudible fetal heart rate on the sonar. She was stabilized with 
intravenous hydration and antihypertensive drugs, the ultrasonography showed 
placental abruption and fetal death. An uneventfully caesarean operation was 
performed under general anaesthesia. Due to the low haemoglobin, haematocrit 
and platelet levels, she received blood transfusion, progressing with clinical and 
laboratory improvement. The pressure control was met by the use of methyldopa, 
nifedipine and pindolol, and she was discharged with a good health status at the 
10th day of hospitalization, with scheduled return for reassessment.    
Keywords: HELLP syndrome, severe preeclampsia, fetal death, placental 
abruption. 
 
RESUMO 
A síndrome HELLP – definida por hemólise, enzimas hepáticas elevadas e 
plaquetopenia – consiste em estágio avançado de pré-eclâmpsia (PE), podendo 
afetar 0,6% das gestações e 4-12% das pacientes com PE grave. Responsável por 
elevados índices de mortalidade materna e perinatal, pode se apresentar com mal 
estar geral, epigastralgia, dor em hipocôndrio direito, náuseas ou vômitos, 
cefaleia, escotomas, assoaciado a quadro hipertensivo e proteinúria. Mulher de 19 
anos, primigesta, admitida com 29 semanas de idade gestacional com quadro de 
hipertensão arterial (160/120 mmHg), cefaleia, escotomas, náuseas e vômitos. 
Apresentava regular estado geral, hipocorada, colo uterino fechado, anterior, 
amolecido e sem perdas e batimento cardiofetal inaudível ao sonar. Estabilizada 
com hidratação venosa e anti-hipertensivos, foi realizada ultrassonografia que 
evidenciou descolamento prematuro de placenta e óbito fetal. Realizada cesariana 
sob anestesia geral sem intercorrências. Devido a baixos níveis de hemoglobina, 
hematócrito e plaquetas, foi hemotransfundida, apresentando melhora clínica e 
laboratorial. O controle pressórico foi atingido com uso de metildopa, nifedipina e 
pindolol, recebendo alta em bom estado geral no 10º dia de internação hospitalar 
com programação de retorno para reavaliação. 
Palavras-chave: Síndrome HELLP, Pré-eclâmpsia grave, óbito fetal, descolamento 
placentário. 
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INTRODUCTION 
 Preeclampsia (PE) consists of a multisystem disorder 
that occurs during pregnancy or puerperium, and it is the main 
cause of maternal and fetal mortality
1
. It presents after the 
20
th
 week of pregnancy with hypertension – systolic arterial 
pressure (SAP) ≥ 140 mmHg and/or diastolic arterial pressure 
(DAP) ≥ 90 mmHg – associated with proteinuria (> 300 
mg/dL)
2
. The severe PE is defined by SAP ≥ 160 mmHg and/or 
DAP ≥ 110 mmHg, and it can be followed by proteinuria ≥ 5 
g/day, oliguria (< 500 mL/day), elevated serum creatinine, 
fetal growth restriction, pulmonary edema, neurologic 
manifestations (headache, visual disturbances, seizure or 
stroke), hepatic manifestations or HELLP syndrome (Hemolysis 
Elevated Liver enzymes Low Platelets), condition described by 
Louis Weinstein in 1982
3
. 
 The HELLP syndrome consists of an advanced staged 
of PE
3,4
 and it can affect 0,6% of gestations and 4-12% of 
patients with severe PE, developing high maternal (24%) and 
perinatal (up to 40%) mortality rates
5,6
. It presents clinically 
with unspecific symptoms, such as general malaise, 
epigastralgia, right hypochondrium pain, nausea and vomits, 
headache and scotomas. The thrombocytopenia can lead to 
the development of mucosal haemorrhage, petechiae or 
ecchymosis. The arterial hypertension, although frequent, may 
be absent in 12-18% of pregnant women and the proteinuria 
may not be detected in 13% of the cases
1
. 
 The diagnosis can be made through the criteria 
stablished by the American College of Obstetricians and 
Gynecologists’ Task Force on Hypertension in Pregnancy, 
which are: haemolysis, at least two of the following 
manifestations: peripheral blood smear with schizocytes or 
echinocytes, serum bilirubin ≥ 1,2 mg/dL, low serum 
haptoglobin or severe anemia not related to blood loss; 
elevated liver enzymes (aspartate aminotransferase – AST – or 
alanine aminotransferase – ALT – and  lactate dehydrogenase 
– DHL – twice higher than the reference values or more); and 
thrombocytopenia (< 100.000/mm
3
)
1
. 
 Regarding the platelets count, there are three HELLP 
syndrome categories
4
: class I if the platelets count is lower 
than 50.000/mm
3
; class II if the count is between 50.000/mm
3
 
and 100.000/mm
3
; and class III if it is higher than 
100.000/mm
3
. 
 The HELLP syndrome can lead to severe maternal 
complications, such as disseminated intravascular coagulation, 
which is the most common, followed by hematoma or hepatic 
rupture
1,6
. Regardless of gestational age, women with the 
HELLP syndrome need termination of pregnancy after clinical 
stabilization or the presence of one or more of the following 
factors: fetal death, placental abruption (PA), pulmonary 
edema, hepatic hemorrhage or stroke
7
. 
CASE REPORT 
 Nineteen-years-old woman, white, married, residing 
in Rio dos Bois, state of Tocantins, Brazil. Primigest, admitted 
to the emergency department of the Dona Regina Siqueira 
Campos Maternity Hospital (HMDR), Palmas, Tocantins, with 
29 weeks of gestational age – based on an ultrasonography 
(USG) of 15 weeks – referred from the Miracema Regional 
Hospital showing arterial hypertension, headache, scotomas, 
nauseas and vomits. She reported at the time of the 
consultation that she was under treatment for urinary tract 
infection (UTI). She used hydralazine and methyldopa at the 
previous hospital. On the physical examination, she presented 
with hypertension (arterial pressure of 160/120 mmHg), 
regular health status and pallid. The fetal heart rate was 
inaudible on the sonar. The vaginal examination revealed a 
closed, anterior and soft cervix, with no fluid losses.  
 She was referred to the monitoring room with the 
diagnostic hypothesis of pregnancy-specific hypertensive 
disorder (PSHD). An obstetric USG and laboratory tests were 
requested and intravenous hydration with ringer’s lactate 
solution was performed; hydralazine, magnesium sulphate 
(MgSO4) and antibiotic therapy with ceftriaxone and 
metronidazole were administered. 
 The USG showed a probable PA of eight cm and fetal 
death (approximately 29 weeks of pregnancy). The initial 
management was inducing labour with misoprostol (25 g), 
strictly monitoring the clinical evolution. After that, the test 
results became available and demonstrated HELLP syndrome 
class II (Table 1). The labour induction was then suspended 
and emergency caesarian was indicated. 
Eight hours after admission, the patient was referred 
to the surgical center, conscious and oriented, to undergo a 
caesarian section. The extraction of the dead fetus was done 
under general anesthesia, with a Pfannenstiel incision. The 
procedure was reportedly uneventful. After the discharge of 
the post-anesthesia recovery room (PAR), the patient was 
referred again to the emergency department. Due to the low 
haemoglobin, haematocrit and platelet levels (Table 1), she 
received two packed red blood cells transfusions (801mL total) 
and two fresh frozen plasmas (521 mL total), in addition to 
one ampoule of dexamethasone (2 mg). The HELLP syndrome 
severity, defined by the platelets count, decreased from class 
II to class I. The patient showed clinical and laboratory 
improvement at the hours following blood transfusion (Figure 
1 and 2). After stabilization, she was transferred to 
gynaecologic ward and a strict pressure control was 
maintained (Table 2). 
At the ward, the patient continued treating with 
methyldopa (500 mg 8/8h), maintaining hypertensive peaks 
and reporting nauseas and scotomas, making it necessary the 
use of hydralazine. After changing the prescription to captopril 
(50 mg 12/12 h), pindolol (10 mg 12/12 h) and nifedipine (20 
mg if AP ≥ 160/110 mmHg), the pressure levels were still not 
controlled (170x100 mmHg). Nevertheless, there was a clinical 
improvement and the cardiology team assessment was 
requested (Day 6 - D6), which prescribed methyldopa (500 mg 
8/8h), nifedipine (20 mg 8/8h) and pindolol (10 mg 12/12h). 
After a new anti-hypertensive regimen, the patient progressed 
asymptomatic and with improvement of pressure levels and 
laboratory results (Table 2). 
 At D9, a swelling at the edge of the surgical wound, 
with approximately 5 cm in diameter, a softened consistency 
and no phlogistic signs, and an USG was ordered. The test  
evidenced a fluid collection with a non-specific aspect, 
suggestive of hematoma (Figure 4). 
At D10, after abdominal wall drainage (Figure 5), the 
patient was discharge of the hospital asymptomatic, with  
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good health status and a significant clinical and laboratory 
improvement. A return to reassessment was requested, at 
first weekly, to the emergency department of this same 
hospital. 
Figure 1. Evolution of the hematimetric numbers according to the 
hospitalization period. 
 
Captions: Hb – hemoglobin; Ht – hematocrit; Hemot – 
hemotransfusion. 
Figure 2. Evolution of the platelet levels according to the 
hospitalization period. 
 
DISCUSSION 
 Women at the perimenopause have increased 
incidence of complications during pregnancy, such as PE and  
    Table 1. Laboratory tests according to day and hour of hospitalization. 
Days D1 D2 D3 D4 D5 D6 D7 D9 
Hours 2h 15h 26h 45h 53h 69h 94h 118h 146h 194h 
Complete blood count (CBC) 
Hb (g/dL) 12,8 7,5 6,5 10,3 11,3 ─ 10,3 10,7 10,4 11,6 
Ht (%) 36,5 21,9 18,2 29,1 32,1 ─ 28,8 30,8 30,1 33,9 
Leuk (cel/mm³) 19.631 ─ 22.060 21.480 16.980 ─ 10.860 10.340 11.070 10.220 
Plat (cel/mm³) 58.000 ─ 35.000 31.000 34.000 40.000 65.000 79.000 111.000 204.000 
Liver function 
AST (U/L) 56,0 ─ ─ 20,0 ─ ─ 26,0 43,0 ─ 23 
ALT (U/L) 20,0 ─ ─ 14,0 ─ ─ 11,0 20,0 ─ 18 
Bilir           
   Dir (mg/dL) 0,34 ─ ─ 0,09 ─ ─ 0,30 ─ ─ 0,18 
   Ind (mg/dL) 1,38 ─ ─ 0,27 ─ ─ 0,32 ─ ─ 0,35 
Renal function 
Ur (mg/dL) 72,0 ─ ─ 60,0 ─ ─ 41,0 36,0 ─ 17,0 
Cr (mg/dL) 1,7 ─ ─ 1,4 ─ ─ 1,2 1,1 ─ 0,9 
Cell lysis markers 
Ác úr (mg/dL) 6,1 ─ ─ 3,1 ─ ─ ─ ─ ─ 2,4 
LDH (U/L) 987,0 ─ ─ 1.006 ─ ─ 674,0 702,0 732,0 614,0 
Coagulogram 
PT (s) 12,2 ─ ─ ─ 12,2 12,2 ─ ─ ─ ─ 
aPTT (s) 30,0 ─ ─ ─ 30,0 30,0 ─ ─ ─ ─ 
Analytical urine test and sedimentocopy 
Ptn (mg/dL) 30,0  neg 100   neg tr neg neg 
RBC (cell/mL) 180.000 ─ 71.000 2.500 ─ ─ 20.000 215.000 1.000 2.000 
Leuk (cell/mL) 94.000 ─ 42.000 10.000 ─ ─ 3.000 16.000 3.000 3.000 
Captions: D – days; h – hous; Hb – hemoglobin; Ht – hematocrit; Leuk – leukocytes; Plat – platelets; AST – 
aspartate aminotransferase; ALT – alanine aminotransferas; Bilir – bilirubins; Dir – direct bilirubin; Ind – 
indirect bilirubin; Ur – urea; Cr – creatinine; Ur ac – uric acid; LDH – lactate dehydrogenase; PT – 
prothrombin time; aPTT – activated partial thromboplastin time; Ptn – protein; RBC – red blood cells. 
 
Table 2. Arterial pressure levels (mmHg) per hour and hospitalization period. 
Hour Days of hospitalization 
D1  D2  D3  D4 D5 D6 D7 D8 D9 D10 D11 
06:00 ─ 100/70 150/90 150/80 170/90 160/100 150/90 130/80 140/100 140/100 140/100 
10:00 ─ 140/80 150/90 170/100 150/90 170/110 130/90 130/80 140/90 140/100 130/80 
14:00 160/120 110/70 ─ 155/90 170/100 150/100 140/90 130/80 160/110 130/90 ─ 
18:00 140/90 ─ 150/80 140/90 130/70 130/70 140/100 ─ 140/100 120/80 ─ 
22:00 150/110 ─ 140/80 150/70 160/100 130/90 120/70 140/90 140/80 110/80 ─ 
Captions: D – days; “systolic arterial pressure/diastolic arterial pressure” (mmHg) data. 
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Figure 4. Elongated fluid collection in the anterossuperior abdominal 
wall, located right above the surgical bed, discreetly heterogeneous, 
measuring about 18.0 x 6.7 x 0.8 cm (volume = 50 cm
3
). 
 
Figure 5. Hematoma in hypogastrium three days after discharge. 
Image provided by the patient. 
 
HELLP syndrome
8
. This presentation of the severe PE 
originates from an abnormal placental development, which 
progresses with the production of factors that lead to 
endothelial injury through the activation of platelets and/or 
vasoconstrictor agents
4
. This patient, differently from the 
usual, was 19 years old. 
 On the other hand, being primigest is considered a 
risk factor to the HELLP syndrome
9,10
, and the recurrence risk 
is 14-24%
11
. In face of headache, scotomas, nauseas and 
vomits, associated with arterial hypertension, the diagnostic 
hypothesis was set, which was confirmed in a few hours by 
laboratory tests, leading to the obtained therapeutic success. 
Literature says that, in light of this condition, the main goal  
must be the management of the patient’s arterial pressure 
with anti-hypertensive therapy and the seizure control. The 
administered magnesium sulfate is recommended to these 
two functions
12
.  The maintenance treatment with magnesium 
sulfate is suggested during the postpartum period because of 
its vasodilator effect on decreasing the maternal mortality
13
. 
 This syndrome is frequently related to perinatal 
hypoxia, a severe complication that can lead to impairments 
throughout life
14
. Therefore, we can consider that the hypoxia, 
caused by both the syndrome pathogeny and the PA, led to 
the fetal death. The leukocytosis observed in D1 could be due 
to the current UTI, associated with the fetal death
15
. 
 Although discrete, the transaminases are related to 
the hepatic involvement, associated with an impaired renal 
function and the cell lysis, evidenced by LDH elevation and a 
severe thrombocytopenia. The endothelial lesion of the liver 
vessels, followed by platelets activation, aggregation and 
consumption, resulting in ischemia and hepatocytes death, is 
the main hypothesis to explain the laboratorial picture of this 
syndrome
5
. 
CONCLUSION 
The PA, along with the hemolysis characteristic of the HELLP 
syndrome, is consisted by the probable causes of hematocrit 
and hemoglobin decrease in the first hours of hospitalization. 
The blood transfusion enabled a significant improvement in 
the hematimetric values and the patient stabilization. Thus, 
due to a prompt medical attention, strict monitoring and 
adequate treatment, a therapeutic success was reached. 
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